Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CLMT
CLMT logo

CLMT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Calumet Inc (CLMT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
34.920
1 Day change
0.78%
52 Week Range
38.750
Analysis Updated At
2026/06/05
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

CLMT is not a strong buy right now for a Beginner investor focused on long-term holding, even with $50,000-$100,000 available. The stock is technically strong and near resistance, but it is also overbought and lacks fresh news or clear fundamental momentum. My direct view is to hold off on buying now and wait for a better entry after momentum cools or for a clearer fundamental catalyst.

Technical Analysis

CLMT shows a bullish short-term trend: MACD histogram is positive and expanding, and the moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). However, RSI_6 is 88.417, which is extremely overbought, suggesting the recent move may be stretched. The stock closed at 37.42, just under R1 resistance at 37.936, with the next upside target near 39.592 and support at 35.254. The trend is upward, but the current entry point is not ideal because price is extended and near resistance.

Options Data

Bearish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Options sentiment is mildly bearish to cautious based on put-heavy volume and put open interest. Open interest put-call ratio at 1.13 shows slightly more puts than calls, while volume put-call ratio at 2.68 shows notably stronger put activity today. Implied volatility is moderate at 53.59 with IV rank 16.53 and IV percentile 26.59, so options are not pricing in extreme fear. Overall, options traders appear to be leaning defensive rather than aggressively bullish.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
1
Buy
9

Positive Catalysts

  • ["Bullish technical structure with SMA_5 > SMA_20 > SMA_200", "MACD histogram is positive and expanding", "Analyst target increases earlier in the year reflected optimism around renewable fuels and base oil margins", "Base oil margins have been highlighted as strong due to Middle East-related disruptions"]

Neutral/Negative Catalysts

  • ["RSI is extremely overbought, which weakens the quality of a new entry", "No news in the recent week, so there is no fresh catalyst driving the stock", "Insiders are selling, with selling increasing 261.65% over the last month", "Goldman Sachs downgraded the stock to Neutral from Buy in April due to valuation", "Options flow is put-heavy, suggesting cautious sentiment", "The stock is sitting close to resistance rather than at a discount"]

Financial Performance

No latest-quarter financial snapshot was available because of a data error, so I cannot verify recent revenue, earnings, or margin trends from this dataset. Based on the available context, the stock appears to be trading more on sector and margin expectations than on a clearly reported fresh quarterly acceleration. The latest quarter season is not provided in the data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mixed. TD Cowen recently raised the target to $34 but kept Hold, citing strong base oil margins as a short-term benefit. Goldman Sachs downgraded to Neutral from Buy in April on valuation, though it raised its target to $36. Earlier in March, Goldman upgraded the target to $34 and kept Buy, while H.C. Wainwright was much more bullish, raising its target to $60 and keeping Buy on improving renewable fuels demand. Overall, the Street view is split: constructive on industry margins and renewable fuels, but cautious on valuation and durability. The pros see margin-driven upside; the cons see the stock as somewhat stretched and only partially supported by near-term fundamentals.

Wall Street analysts forecast CLMT stock price to fall
3 Analyst Rating
Wall Street analysts forecast CLMT stock price to fall
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 34.920
sliders
Low
19
Averages
23.67
High
28
Current: 34.920
sliders
Low
19
Averages
23.67
High
28
TD Cowen
Hold
maintain
$25 -> $34
AI Analysis
2026-06-03
Reason
TD Cowen
Price Target
$25 -> $34
AI Analysis
2026-06-03
maintain
Hold
Reason
TD Cowen raised the firm's price target on Calumet to $34 from $25 and keeps a Hold rating on the shares. The firm says base oil margins have hit post-Covid highs due to the Middle East conflict. Calumet should benefit from its base oil capacity, though it is mostly tied to Group I/II base oil margins, meaning it may only be a short-term positive, the analyst tells investors in a research note.
Goldman Sachs
Buy -> Neutral
downgrade
$34 -> $36
2026-04-24
Reason
Goldman Sachs
Price Target
$34 -> $36
2026-04-24
downgrade
Buy -> Neutral
Reason
Goldman Sachs downgraded Calumet to Neutral from Buy with a price target of $36, up from $34. The firm cites valuation for the downgrade following the stock's outperformance over the last 12 months. Goldman remains constructive on the outlook for renewable diesel margins, but remains selective in its stock selections.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CLMT
Unlock Now

People Also Watch